Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.

Rassy, Elie; Le Roy, Florence; Smolenschi, Cristina; Valéry, Marine; Boige, Valérie; Ducreux, Michel; Boilève, Alice

Rassy, Elie; Le Roy, Florence; Smolenschi, Cristina; Valéry, Marine; Boige, Valérie; Ducreux, Michel; Boilève, Alice.

Afiliação

Rassy E; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Le Roy F; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Smolenschi C; Service de Gastroentérologie, Groupe Hospitalier Bretagne Sud, Hôpital du Scorff, Lorient, France.
Valéry M; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Boige V; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Ducreux M; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Boilève A; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.

JAMA Oncol ; 9(3): 434-435, 2023 03 01.

Article em En | MEDLINE | ID: mdl-36701137

This cohort study assesses the outcome of oxaliplatin desensitization for patients with gastrointestinal cancers who experienced hypersensitivity reactions after oxaliplatin infusion.

Assuntos

Antineoplásicos; Neoplasias Colorretais; Humanos; Oxaliplatina/efeitos adversos; Antineoplásicos/efeitos adversos; Neoplasias Colorretais/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Antineoplásicos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google